Nuwellis Inc. Stock
Nuwellis Inc. Stock
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Nuwellis Inc. stock is not clear.
With a target price of 15 € there is potential for a 13057.89% increase which would mean more than doubling the current price of 0.11 € for Nuwellis Inc..
So far the community has only identified positive things for Nuwellis Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Nuwellis Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nuwellis Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nuwellis Inc. | - | - | - | - | - | - | - |
| MicroVision Inc | 0.940% | 14.175% | 19.067% | -48.398% | -59.176% | -90.563% | 86.775% |
| Fonar Corp. New | 4.610% | 8.163% | 4.605% | 6.000% | -10.169% | 11.972% | -23.355% |
| Allscripts Healthcare | 6.670% | 0.000% | -2.439% | -28.571% | -13.514% | -29.825% | -15.496% |
Comments
Nuwellis, Inc. (NASDAQ: NUWE) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $17.00 price target on the stock.
Show more
Ratings data for NUWE provided by MarketBeat
Nuwellis, Inc. (NASDAQ: NUWE) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $17.00 price target on the stock.
Show more
Ratings data for NUWE provided by MarketBeat